UMR1227, Lymphocytes B et Autoimmunité, Univ Brest, Brest, France.
Laboratoire d'Immunologie et Immunothérapie, CHU de Brest, Brest, France.
Clin Rev Allergy Immunol. 2020 Apr;58(2):151-154. doi: 10.1007/s12016-019-08740-1.
The innate immune response provides a first line of defense against common microorganisms and, for more complex and/or recurring situations where pathogens must be eliminated, an adaptive immune response has emerged and evolved to provide better protection against subsequent infections. However, such dichotomy has to be reevaluated because innate B cells (e.g., B1 and marginal zone B cells) and the newly described innate lymphoid cells (iLC) have been found to exhibit innate-like properties, such as antigen internalization, regulatory B cell functions, and helper T cell activities. In addition, the production and function of natural antibodies (nAbs) by innate B cells and their capacity to activate the classical complement pathway constitute additional important mechanisms at the junction of innate and adaptive immunity as well as the recent integration of platelets into the innate immune spectrum. There is no doubt that these mechanisms present an advantage in immunity and homeostasis particularly during the first years of life, but arguments are arising to consider that these precursors may have detrimental effects in a variety of autoimmune/inflammatory diseases, allergies and cancers, as well as in response to immunotherapy. Accordingly, and as presented in this special issue of Clinical Reviews in Allergy and Immunology, a better comprehension of the key molecular and cellular actors implicated at the crossroads of the innate and adaptive immune response represents a new challenge in our understanding of the immunological and immunopathological responses.
先天免疫反应为抵抗常见微生物提供了第一道防线,而对于更复杂和/或反复出现的病原体必须被清除的情况,适应性免疫反应已经出现并进化,以提供更好的针对后续感染的保护。然而,这种二分法必须重新评估,因为先天 B 细胞(例如 B1 和边缘区 B 细胞)和新描述的先天淋巴细胞(iLC)被发现具有先天样特性,如抗原内化、调节 B 细胞功能和辅助 T 细胞活性。此外,先天 B 细胞产生和功能的天然抗体(nAbs)及其激活经典补体途径的能力构成了先天免疫和适应性免疫交界处的另外重要机制,以及最近将血小板纳入先天免疫谱。毫无疑问,这些机制在免疫和动态平衡中尤其在生命的最初几年提供了优势,但也出现了争论,认为这些前体细胞可能在各种自身免疫/炎症性疾病、过敏和癌症中以及对免疫治疗的反应中产生有害影响。因此,正如在《过敏与免疫学临床评论》的这个特刊中所呈现的,更好地理解先天和适应性免疫反应交叉点涉及的关键分子和细胞因子代表了我们对免疫和免疫病理反应理解的新挑战。